TherAchon AG

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharma

Albert Bourla On What The Street Has Wrong About Pfizer Pfizer Inc. CEO Albert Bourla is one year into the job and tried to impress upon J.P. Morgan Healthcare Conference attendees at a fireside cha

Albert Bourla On What The Street Has Wrong About Pfizer Pfizer Inc. CEO Albert Bourla is one year into the job and tried to impress upon J.P. Morgan Healthcare Conference attendees at a fireside cha

Billions of dollars flowed into biopharmaceutical companies in the first full week of January with $5.5bn in new funding for private and public drug developers revealed in new investment funds, includ